DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
T••••••• H•••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Tecomet
Principal held
at least $258M
sum of BDC pieces, a lower bound
Fair value
$258M
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
7
5 on the latest quarter
Facilities
3
1 equity pieces beside them
Next maturity
May 12, 2032
no dated debt inside 24 months
On the tape since
Dec 31, 2021
latest Jun 30, 2026
Events
6
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| other lien unstated | at least $237M | 101c | 10.39% PIK 6.75% | May 12, 2032 | 5 |
| first lien term loan first lien | at least $21.2M | 102c | S+675 bp PIK 10.39% | May 12, 2032 | 2 |
| second lien term loan second lien exited Mar 31, 2023 | at least $5.0M | 91c | S+850 bp | Nov 1, 2024 | 2 |
Equity pieces beside the debt: equity ($4,000 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| C••••••• C•••••• B••• I••• | equity equity Investment T••• C••••• S•••• | Not disclosed | $4,000 1c | |
| H•• C•••••••• C•••••• S•••••••• F••• | unstated lien unstated N••••••••• I••••• | $13.6M | $13.6M 101c | 10.39% PIK 6.75% |
| H•• C•••••••• L•••••• F••• | unstated lien unstated N••••••••• I••••• | $223M | $223M 101c | 10.39% PIK 6.75% |
| O•• S••••• P•••••• L•••••• F••• •• L•• | term loan first lien F•••• L••• D••• | $4.3M | $4.3M 101c | S+675 bp PIK 10.39% |
| T• R••• P•••• O•• S••••• P•••••• C••••• F••• | term loan first lien F•••• L••• D••• | $16.9M | $16.9M 102c | S+675 bp PIK 10.39% |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 5 | $258M | $258M | 101c | 4 |
| Mar 31, 2026 | 4 | $21.2M | $21.2M | 102c | 0 |
| Dec 31, 2025 | 4 | $169M | $169M | 101c | 0 |
| Sep 30, 2025 | 4 | $148M | $148M | 101c | 0 |
| Jun 30, 2025 | 4 | $148M | $145M | 99c | 0 |
| Mar 31, 2025 | 4 | $148M | $145M | 99c | 2 |
| Dec 31, 2024 | 4 | $314M | $311M | 101c | 8 |
| Sep 30, 2024 | 4 | $145M | $143M | 101c | 3 |
| Jun 30, 2024 | 4 | $143M | $145M | 103c | 3 |
| Mar 31, 2024 | 4 | $142M | $141M | 102c | 3 |
| Dec 31, 2023 | 4 | $140M | $139M | 101c | 3 |
| Sep 30, 2023 | 4 | $138M | $137M | 101c | 1 |
| Jun 30, 2023 | 1 | $0 | $0 | n/a | 0 |
| Mar 31, 2023 | 1 | $5.0M | $4.5M | 91c | 0 |
| Dec 31, 2022 | 3 | $66.2M | $55.9M | 85c | 0 |
| Sep 30, 2022 | 2 | $35.4M | $32.5M | 93c | 0 |
| Dec 31, 2021 | 2 | $60.5M | $57.6M | 96c | 0 |
What changed
- Spread changed (observed)Jun 30, 2026
- PIK interest appearsJun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- New lender joined a facilityJun 30, 2026
- PIK interest appearsJun 30, 2026
- PIK interest appearsJun 30, 2026
- PIK interest appearsJun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- Maturity extended (observed)Jun 30, 2026
- Lender left a facilityDec 31, 2025
- Lender left a facilityDec 31, 2025
- PIK interest appearsDec 31, 2023
- PIK interest appearsDec 31, 2023
- New lender joined a facilitySep 30, 2023
- New lender joined a facilitySep 30, 2023
- New lender joined a facilitySep 30, 2023
- Facility left every BDC scheduleMar 31, 2023
- Mark recoveredMar 31, 2023
- Lender left a facilityDec 31, 2022
- Marked down across lendersDec 31, 2022
- New lender joined a facilityDec 31, 2022
- Marked down (one lender)Dec 31, 2022
- Marked down (one lender)Dec 31, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- TECOSTARderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 7 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it